HEXO Corp. Total Shareholders Equity 2011-2026 | HEXO

Annual Total Shareholders Equity HEXO Corp.

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
314 M	732 M	557 M	789 M	323 M	32.4 M	-	-	-	-	-	-

All numbers in CAD currency

Indicator range from annual reports

Maximum	Minimum	Average
789 M	32.4 M	458 M

Quarterly Total Shareholders Equity HEXO Corp.

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	314 M	-	-	-	732 M	732 M	-	-	557 M	557 M	-	-	789 M	789 M	-	-	323 M	323 M	-	-	-	32.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in CAD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
789 M	32.4 M	515 M

Total Shareholders Equity of other stocks in the Drug manufacturers industry

Issuer	Total Shareholders Equity	Price	% 24h	Market Cap	Country
Cumberland Pharmaceuticals CPIX	24.9 M	$ 6.45	9.88 %	$ 95.8 M	USA
Endo International plc ENDP	-6.6 B	-	-	$ 28.9 M	Irlanda
Evoke Pharma EVOK	7.04 M	-	-	$ 36.6 M	USA
Calliditas Therapeutics AB (publ) CALT	766 M	-	-0.1 %	$ 2.03 B	Schweden
AcelRx Pharmaceuticals ACRX	17 M	-	7.5 %	$ 6.35 M	USA
DURECT Corporation DRRX	9.13 M	-	-	$ 50.1 M	USA
Adamis Pharmaceuticals Corporation ADMP	-808 K	-	0.86 %	$ 117 M	USA
Aerie Pharmaceuticals AERI	-17.3 M	-	-	$ 754 M	USA
Agile Therapeutics AGRX	-16.3 M	-	10.11 %	$ 58.2 M	USA
Alimera Sciences ALIM	46.2 M	-	-	$ 142 M	USA
Cronos Group CRON	1.09 B	$ 2.74	-	$ 1.05 B	Canada
Athenex ATNX	-6.51 M	-	-23.39 %	$ 1.76 M	USA
Harrow Health HROW	52.4 M	$ 32.99	-0.03 %	$ 1.21 B	USA
Avadel Pharmaceuticals plc AVDL	73.8 M	-	-	$ 2.06 B	France
Catalent CTLT	3.6 B	-	-	$ 11.5 B	USA
Pacira BioSciences PCRX	778 M	$ 23.61	1.11 %	$ 1.09 B	USA
Eagle Pharmaceuticals EGRX	234 M	-	-39.89 %	$ 27.7 M	USA
Bausch Health Companies BHC	-554 M	$ 5.52	0.91 %	$ 2.05 B	Canada
Organogenesis Holdings ORGO	300 M	$ 2.61	-2.07 %	$ 331 M	USA
Canopy Growth Corporation CGC	487 M	$ 1.06	2.19 %	$ 114 M	Canada
Solid Biosciences SLDB	180 M	$ 6.87	3.63 %	$ 601 M	USA
Aurora Cannabis ACB	609 M	$ 3.5	1.16 %	$ 192 M	Canada
Sonoma Pharmaceuticals SNOA	4.41 M	$ 1.08	-1.82 %	$ 1.34 M	USA
Jupiter Wellness JUPW	35 M	-	-	$ 33.6 M	USA
Tilray TLRY	3.32 B	$ 5.47	3.4 %	$ 3.38 B	Canada
Lannett Company LCI	-251 M	-	1.15 %	$ 7.11 M	USA
OrganiGram Holdings OGI	306 M	$ 1.14	1.34 %	$ 109 M	Canada
Evolus EOLS	-23.1 M	$ 6.07	-0.33 %	$ 391 M	USA
Sundial Growers SNDL	270 M	$ 1.45	-	$ 3.37 M	Canada
Emergent BioSolutions EBS	523 M	$ 8.92	5.56 %	$ 477 M	USA
Veru VERU	18.3 M	$ 2.37	0.85 %	$ 34.7 M	USA
Neoleukin Therapeutics NLTX	265 M	-	-	$ 193 M	Canada
Assertio Holdings ASRT	94 M	$ 23.45	0.04 %	$ 150 M	USA
ProPhase Labs PRPH	63.6 M	-	-	$ 5.07 M	USA
Radius Health RDUS	-252 M	-	-	$ 1.42 B	USA
cbdMD YCBD	7.23 M	$ 0.75	-1.02 %	$ 3.02 M	USA
PetIQ PETQ	223 M	-	1.64 %	$ 400 M	USA
Relmada Therapeutics RLMD	86.5 M	$ 6.92	-1.76 %	$ 273 M	USA
Recro Pharma REPH	58.7 M	-	-4.76 %	$ 65.3 M	USA
OptiNose OPTN	-86.6 M	-	-	$ 1.08 B	USA
SCYNEXIS SCYX	49.4 M	$ 0.72	-1.82 %	$ 36 M	USA
PLx Pharma PLXP	35.7 M	-	-27.8 %	$ 2.56 M	USA
Viatris VTRS	14.7 B	$ 16.49	-0.99 %	$ 19.3 B	USA
Zomedica Corp. ZOM	115 M	-	-0.21 %	$ 98 M	USA
Zynerba Pharmaceuticals ZYNE	46.2 M	-	-	$ 55.5 M	USA
Rockwell Medical RMTI	37 M	$ 0.77	-2.98 %	$ 27.7 M	USA
Tricida TCDA	218 K	-	-	$ 3.25 M	USA
China Pharma Holdings CPHI	22.7 M	$ 0.79	4.63 %	$ 3.39 M	China
TherapeuticsMD TXMD	26.9 M	$ 2.11	-0.47 %	$ 24.4 M	USA